Primary Objectives 1.Evaluation of safety and tolerability after repeated administration of injectable Lipivirtide in HIV-infected patients not receiving antiretroviral therapy Secondary Objectives 1. Evaluation of the pharmacokinetic properties of injectable Lipovirtide after multiple administrations in HIV-infected patients not receiving antiretroviral therapy, to obtain pharmacokinetic parameters. 2. Evaluation of the efficacy of injectable Lipovirtide for HIV in HIV-infected patients not receiving antiretroviral therapy. 3. Evaluation of the immunogenicity of lipovirtide for injection.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes from baseline in respiration rate of Vital Signs.
Timeframe: Within 50 days after the first administration.
Changes from baseline in Blood lactate of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in Pregnancy test of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in Drug resistance test of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in Immunogenic blood collection of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in blood pressure of Vital Signs.
Timeframe: Within 50 days after the first administration.
Changes from baseline in body temperature of Vital Signs.
Timeframe: Within 50 days after the first administration.
Changes from baseline in red blood cell count of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in white blood cell count of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in neutrophil count of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in lymphocyte count of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in platelet count of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in hemoglobin of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in PT of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in INR of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in APTT of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in total bilirubin of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in direct bilirubin of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in ALT of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in AST of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in total protein of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in albumin of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in total bile acid of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in urea of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in creatinine of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in uric acid of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in glucose of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in potassium of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in sodium of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in chlorine of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine specific gravity of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine pH of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine glucose of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine protein of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine ketone body of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine white blood cell of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine bilirubin of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in urine occult blood of Laboratory Examination.
Timeframe: Within 50 days after the first administration.
Changes from baseline in Electrocardiogram.
Timeframe: Within 50 days after the first administration.
Changes from baseline in CK of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in CK-MB of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in LDH of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in ALP of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in Triglyceride of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in CHOL of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in TP of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in ALB of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in UA of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in GLU of Laboratory Examination
Timeframe: Within 50 days after the first administration.
Changes from baseline in AMY of Laboratory Examination
Timeframe: Within 50 days after the first administration.